Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

ChemoSen3D

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine.
2018
02-Oct
02-10
Houston, Texas, United States
  • Bioanalytical Devices
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Innovation

R&D Focus

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine

Innovative Solution

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

165.K

Last Funding Amount

165.K

Last Funding Date

24-02-2021

Startup Stage

Seed

About

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine.

Something missing or incorrect on this page? Help us enrich this information